Home » Our Locations » North America » St. Petersburg, USA

ST. PETERSBURG, USA

St. Petersburg is our primary softgel development and manufacturing facility in North America with capacity of 18 billion capsules per year. The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candicates. Non-gelatin based OptiShell® and Vegicaps® capsules expand the range of molecules into softgel, ideal for challenging fill formulation. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges.

Size: 453,000 ft2

ADDRESS

2725 Scherer Drive North,
St. Petersburg, FL 33716

PHONE

+1 727 803 2100

St. Petersburg, FL Location

ACCREDITATIONS

  • EMA/MHRA Approved
  • FDA Approved
  • ANVISA
  • PMDA
  • CFDA (China)
  • MOH (Saudi Arabia, Turkey)
  • MFDS

SALES INQUIRIES

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.

We recognize talent is our most important asset. To explore a career with Catalent, visit our Careers Section to submit your resume, or contact us at careers@catalent.com.